Concepedia

Philip O. Livingston

PO

Statistics

Publications

128

Citations

10.8K

H-Index

66

Active since

1966

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Kettering University

Cornell University

Columbia University

Philip O. Livingston is an author at Memorial Sloan Kettering Cancer Center specializing in immunology, oncology, and cancer immunotherapy.

Publications per year

1966–2022

128

Publications

128

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

Philip O. Livingston, Gabriel Wong, Sucharita Adluri et al. · Journal of Clinical Oncology · 1994 · 520 citations

, , +17

Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

Shengle Zhang, H S Zhang, Carlos Cordon‐Cardo et al. · International Journal of Cancer · 1997 · 294 citations · Full text

, , +16

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

Shengle Zhang, Carlos Cordon‐Cardo, Helen S. Zhang et al. · International Journal of Cancer · 1997 · 278 citations

, , +17

Selective CD4<sup>+</sup> Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications

Y.B. Su, SeJean Sohn, Susan E. Krown et al. · Journal of Clinical Oncology · 2004 · 258 citations · Full text

, , +9

Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

Susan F. Slovin, Govindaswami Ragupathi, Sucharita Adluri et al. · Proceedings of the National Academy of Sciences · 1999 · 253 citations · Full text

, , +17

1–5 of 128